IGC Pharma (IGC) Receivables - Net (2011 - 2026)
IGC Pharma (IGC) reported Receivables - Net of $37000.0 for Q1 2026, up 8.82% year-over-year from $34000.0 in Q1 2025, and up 208.33% quarter-over-quarter from $12000.0 in Q4 2025.
IGC Pharma (IGC) Receivables - Net (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 16 years of Receivables - Net data on file, last reported at $37000.0 in Q1 2026.
- Receivables - Net for Q1 2026 came in at $37000.0, up 8.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $37000.0 (up 8.82% YoY), and the FY2026 annual result was $37000.0, up 8.82% from the prior year.
- Receivables - Net grew to $37000.0 in Q1 2026 per IGC's latest filing, from $12000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $251000.0 in Q4 2022 and troughed at $12000.0 in Q4 2025.
- A 5-year average of $96705.9 and a median of $87000.0 in 2025 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net tumbled 87.56% in 2024, then jumped 210.71% in 2025.
- A 5-year view of Receivables - Net shows it stood at $251000.0 in 2022, then slumped by 63.35% to $92000.0 in 2023, then tumbled by 46.74% to $49000.0 in 2024, then sank by 75.51% to $12000.0 in 2025, then jumped by 208.33% to $37000.0 in 2026.
- Business Quant data shows IGC's Receivables - Net at $37000.0 in Q1 2026, $12000.0 in Q4 2025, and $41000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |